Fairness opinions › Acquirers
Globus Medical: healthcare acquisitions with fairness opinions
2 public-company targets, 2023-2025, $3.4B combined enterprise value. The multiples Globus Medical paid and the banker analyses behind each target board's recommendation.
Deals
2
Median EV / EBITDA paid
10.6x
Median EV / revenue paid
1.53x
| Announced | Target | Acquirer | Segment | EV | EV/EBITDA | EV/Rev | DCF rate | Fairness opinion |
|---|---|---|---|---|---|---|---|---|
| 2025-02-06 | Nevro | Globus Medical | Medical Devices and Supplies | $250M | — | 0.61x | 12.0%–14.8% | BofA Securities |
| 2023-02-09 | NuVasive | Globus Medical | Medical Devices and Supplies | $3.1B | 10.6x | 2.46x | 7.5%–9.5% |